Abstract Title:

The impact of curcumin on breast cancer.

Abstract Source:

Integr Biol (Camb). 2012 Sep ;4(9):996-1007. Epub 2012 Jul 6. PMID: 22772921

Abstract Author(s):

Ganji Purnachandra Nagaraju, Sheik Aliya, Syed F Zafar, Riyaz Basha, Roberto Diaz, Bassel F El-Rayes

Article Affiliation:

Ganji Purnachandra Nagaraju

Abstract:

Curcumin, the active ingredient of turmeric (curry spice), is believed to be associated with reducing the incidence of breast cancers in Asian countries. Anti-cancer efficacy of curcumin and analogs has been tested in pre-clinical studies in some cancer models including breast cancer. These studies reported promising results in inhibiting human cancer cell proliferation and tumorigenesis in animal models. Both in vitro and in vivo studies have shown that curcumin and its analogs target critical genes associated with angiogenesis, apoptosis, cell cycle, and metastasis. The inhibition of human breast cancer cell growth by curcumin is mediated via certain signaling cascades including the modulation of the NF-κB signaling pathway. Epidemiological and experimental data also demonstrated the efficacy of curcumin in chemoprevention and reversing chemo-resistance of tumors of certain cancers. This review summarizes the studies revealing the preventive and therapeutic effects of curcumin and its analogs withan emphasis on multi-targeted biological and molecular effects in a breast cancer model.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.